IN8bio
(NASDAQ) INAB
IN8bio Financials at a Glance
Market Cap
$14.18M
Revenue (TTM)
$0.00
Net Income (TTM)
$19.44M
EPS (TTM)
$-4.59
P/E Ratio
-0.31
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.40
Volume
400
Open
$1.38
Price
$1.40
Volume
400
Open
$1.38
Previous Close
$1.40
Daily Range
$1.38 - $1.40
52-Week Range
$1.17 - $5.82
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.40
Volume
400
Open
$1.38
Previous Close
$1.40
Daily Range
$1.38 - $1.40
52-Week Range
$1.17 - $5.82
INAB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout IN8bio
Industry
Biotechnology
Sector
Health CareEmployees
17
CEO
William T. Ho, MBA
Website
www.in8bio.comHeadquarters
New York City, NY 10118, US
INAB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-92%
Return on Capital
-67%
Return on Assets
-60%
Earnings Yield
-3.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.18M
Shares Outstanding
9.85M
Volume
400
Short Interest
0.00%
Avg. Volume
73.12K
Financials (TTM)
Gross Profit
$2.50M
Operating Income
$19.86M
EBITDA
$17.36M
Operating Cash Flow
$12.71M
Capital Expenditure
$0.00
Free Cash Flow
$12.71M
Cash & ST Invst.
$27.09M
Total Debt
$2.78M
IN8bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.17M
N/A
Gross Margin
0.00%
N/A
Market Cap
$14.18M
N/A
Market Cap/Employee
$787.77K
N/A
Employees
18
N/A
Net Income
$4.94M
+19.8%
EBITDA
$4.63M
+16.2%
Quarterly Fundamentals
Net Cash
$24.31M
+299.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.56M
-53.8%
Short Term Debt
$1.22M
-26.0%
Return on Assets
-60.22%
N/A
Return on Invested Capital
-67.07%
N/A
Free Cash Flow
$2.14M
+47.3%
Operating Cash Flow
$2.14M
+46.9%